Yiming Wu

Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy

Andrew K. Dilger, Kumar B. Pabbisetty, James R. Corte et al. · Journal of Medicinal Chemistry · 2021 · 93 citations · Full text

Milvexian, an orally bioavailable, small‐molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits

Pancras C. Wong, Earl J. Crain, Jeffrey M. Bozarth et al. · Journal of Thrombosis and Haemostasis · 2021 · 58 citations · Full text

Thrombosis, Direct Inhibitor, Blood Platelet +9

Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212)

Donald Pinto, Michael J. Orwat, Leon M. Smith et al. · Journal of Medicinal Chemistry · 2017 · 50 citations · Full text

Enhanced proton conductivity of multiblock poly(phenylene ether ketone)s via pendant sulfoalkoxyl side chains with excellent H₂/air fuel cell performance

Tiandu Dong, Jiahui Hu, Mitsuru Ueda et al. · Journal of Materials Chemistry A · 2016 · 46 citations

Engineering, Prepared Membranes, Chemistry +17

Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker

James R. Corte, Tianan Fang, Honey Osuna et al. · Journal of Medicinal Chemistry · 2017 · 38 citations · Full text